These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23288575)

  • 1. Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.
    Arevalo-Rodriguez I; Pedraza OL; Rodríguez A; Sánchez E; Gich I; Solà I; Bonfill X; Alonso-Coello P
    Am J Alzheimers Dis Other Demen; 2013 Mar; 28(2):111-9. PubMed ID: 23288575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The new 2011 recommendations of the National Institute on Aging and the Alzheimer's Association on diagnostic guidelines for Alzheimer's disease: Preclinal stages, mild cognitive impairment, and dementia].
    Croisile B; Auriacombe S; Etcharry-Bouyx F; Vercelletto M; ;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):471-82. PubMed ID: 22579080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    McKhann GM; Knopman DS; Chertkow H; Hyman BT; Jack CR; Kawas CH; Klunk WE; Koroshetz WJ; Manly JJ; Mayeux R; Mohs RC; Morris JC; Rossor MN; Scheltens P; Carrillo MC; Thies B; Weintraub S; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):263-9. PubMed ID: 21514250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential neuroimaging biomarkers of pathologic brain changes in Mild Cognitive Impairment and Alzheimer's disease: a systematic review.
    Ruan Q; D'Onofrio G; Sancarlo D; Bao Z; Greco A; Yu Z
    BMC Geriatr; 2016 May; 16():104. PubMed ID: 27184250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
    Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
    Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers in Alzheimer's disease.
    Demarin V; Zavoreo I; Kes VB; Simundić AM
    Clin Chem Lab Med; 2011 May; 49(5):773-8. PubMed ID: 21303300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Takwoingi Y; Flicker L; Mason SE; McShane R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD008782. PubMed ID: 24913723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mild cognitive impairment. Part 2: Biological markers for diagnosis and prediction of dementia in Alzheimer's disease.
    Forlenza OV; Diniz BS; Teixeira AL; Stella F; Gattaz W
    Braz J Psychiatry; 2013; 35(3):284-94. PubMed ID: 24142092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Ritchie C; Smailagic N; Noel-Storr AH; Ukoumunne O; Ladds EC; Martin S
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010803. PubMed ID: 28328043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Visual and Spatial Perception Tests in Alzheimer's Disease: A Systematic Review.
    Scott JP; Murphy DF; Noad RF
    Dement Geriatr Cogn Disord; 2023; 52(4):195-204. PubMed ID: 37271132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological Decline Improves Prediction of Dementia Beyond Alzheimer's Disease Biomarker and Mild Cognitive Impairment Diagnoses.
    Nation DA; Ho JK; Dutt S; Han SD; Lai MHC;
    J Alzheimers Dis; 2019; 69(4):1171-1182. PubMed ID: 31104015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.
    Weissberger GH; Strong JV; Stefanidis KB; Summers MJ; Bondi MW; Stricker NH
    Neuropsychol Rev; 2017 Dec; 27(4):354-388. PubMed ID: 28940127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.
    Jack CR; Albert MS; Knopman DS; McKhann GM; Sperling RA; Carrillo MC; Thies B; Phelps CH
    Alzheimers Dement; 2011 May; 7(3):257-62. PubMed ID: 21514247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective cognitive decline: preclinical manifestation of Alzheimer's disease.
    Lin Y; Shan PY; Jiang WJ; Sheng C; Ma L
    Neurol Sci; 2019 Jan; 40(1):41-49. PubMed ID: 30397816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).
    Martínez G; Vernooij RW; Fuentes Padilla P; Zamora J; Flicker L; Bonfill Cosp X
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD012884. PubMed ID: 29164602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New diagnostic guidelines for Alzheimer's disease by NIA/AA].
    Ihara R
    Nihon Rinsho; 2016 Mar; 74(3):386-94. PubMed ID: 27025074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia.
    Ewers M; Sperling RA; Klunk WE; Weiner MW; Hampel H
    Trends Neurosci; 2011 Aug; 34(8):430-42. PubMed ID: 21696834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EFNS guidelines for the diagnosis and management of Alzheimer's disease.
    Hort J; O'Brien JT; Gainotti G; Pirttila T; Popescu BO; Rektorova I; Sorbi S; Scheltens P;
    Eur J Neurol; 2010 Oct; 17(10):1236-48. PubMed ID: 20831773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.